Eric Rompen is a Professor at the University of Liege and the head of the department of Periodontology – Dental Surgery. He is also coordinating the European University Certificate of oral implantology. His favorite subjects of clinical and experimental research are biomaterials, bone regeneration, biological interface implant/soft issue and osseointegration. His clinical work is focused on gingival muco surgery and implantology.
France Lambert graduated from the University of Liege in Periodontology, where she continued to obtain a PhD in the same subject. She has also completed a fellowship program in oral implantology at the prestigious Harvard School of Dental Medicine as well as the University of Washington.
She is currently Head of Clinic in the Periodontology and Oral Surgery Departement at the University of Liege. Her clinical work is focused exclusively on implantology, mucogingival surgery and periodontics. Her scientific research areas target different aspects of the use of biomaterial and dental implants
Geoffrey Lecloux received a degree in dentistry at the University of Liege. After an assistantship, he received the title of specialist in oral rehabilitation. He specialized in the field of Periodontology and trained at the DU of Paris VII University. He also received the Implant and Periodontology Specialist degree at the University of Liege.
He is currently Head of Clinic in the Prof. Rompen’s Periodontology Dental Surgery service.
It all started in December 2013. After 2 years of research and development supported by the Centre of Technological Resources in Chemistry, Certech (Belgium), the founders Eric Rompen, France Lambert and Geoffrey Lecloux together established Wishbone SA. Together with The Faktory, a private seed investment fund, incubator and accelerator based in Liège, Wishbone set up their production and process development facility in Flémalle.
The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone.
In the early days, the development of the superior biomaterials took place at the highly specialized CRO at Certech, enabling access to the most up-to-date equipment such as SEM and IR, to Certech’s expertise in materials development and its strong reference in the pharmaceutical market. Wishbone biomaterials are in addition tested and developed in close collaboration with the Periodontology/Dental Surgery of the University of Liège (Belgium) enabling access to the University’s infrastructure and network.
- 2013: Wishbone SA was created and incubated by The Faktory, in Liège. Patented its production process.
- 2014: Wishbone SA moved to its brand new facilities in Liège.
- 2015: Commissioning of its industrial production line in cleanroom conditions.
- 2016: Quality Management System implemented.
- 2017: Wishbone SA is certified ISO 13485.